Literature DB >> 24729499

Different recommendations for daptomycin dosing over time in patients with severe infections.

Antonello Di Paolo1, Marialuisa Polillo1, Carlo Tascini2, Russell Lewis3, Francesco Menichetti2, Romano Danesi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24729499     DOI： 10.1093/cid/ciu230

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.

Authors:  Antonio D'Avolio; Debora Pensi; Lorena Baietto; Giovanni Pacini; Giovanni Di Perri; Francesco Giuseppe De Rosa
Journal:  Drugs       Date:  2016-08       Impact factor: 9.546

Review 2.  Clinical Pharmacokinetics of Daptomycin.

Authors:  Nicolas Gregoire; Alexia Chauzy; Julien Buyck; Blandine Rammaert; William Couet; Sandrine Marchand
Journal:  Clin Pharmacokinet       Date:  2020-12-14       Impact factor: 6.447

3.  Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update.

Authors:  Giuseppe Balice; Claudio Passino; Maria Grazia Bongiorni; Luca Segreti; Alessandro Russo; Marianna Lastella; Giacomo Luci; Marco Falcone; Antonello Di Paolo
Journal:  Antibiotics (Basel)       Date:  2022-07-07

4.  Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis.

Authors:  S Piva; Antonello Di Paolo; Laura Galeotti; Francesco Ceccherini; Francesco Cordoni; Liana Signorini; Tommaso Togni; Amedeo De Nicolò; Frank A Rasulo; Nazzareno Fagoni; N Latronico; Antonio D'Avolio
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.